ORIC · Oric Pharmaceuticals, Inc.

$13.87 +0.15 (+1.09%) At close · Aug 14

Market Cap

$1.44B

103.65M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-02-24	Dominic Piscitelli	Officer	52,000	$702,000	2026-02-24	J.P. Morgan Securities LLC
2026-01-16	Richard A, Heyman	Director	7,000	$84,000	2026-01-16	J.P. Morgan Securities LLC
2026-01-16	Richard A, Heyman	Director	6,400	$76,800	2026-01-16	J.P. Morgan Securities LLC
2025-12-16	Piscitelli Dominic	Officer	10,720	$97,129	2025-12-16	E-Trade Financial Corporation
2025-12-16	Multani Pratik S	Officer	10,720	$97,129	2025-12-16	E-Trade Financial Corporation
2025-12-16	Chacko Jacob	Officer, Director	33,374	$302,370	2025-12-16	E-Trade Financial Corporation
2025-10-06	Dominic Piscitelli	Officer	50,000	$725,000	2025-10-06	J.P. Morgan Securities LLC
2025-09-22	Jacob Chacko	Director, Officer	250,000	$2,625,000	2025-09-22	J.P. Morgan Securities LLC
2025-06-06	Dominic Piscitelli	Officer	60,000	$540,000	2025-06-06	J.P. Morgan Securities LLC
2024-12-16	Chacko Jacob	Officer, Director	24,660	$204,215	2024-12-16	E-Trade Financial Corporation
2024-12-16	Piscitelli Dominic	Officer	8,851	$73,298	2024-12-16	E-Trade Financial Corporation
2024-12-16	Multani Pratik S	Officer	8,850	$73,294	2024-12-16	E-Trade Financial Corporation
2024-03-06	Jacob Chacko	Director	40,000	$648,380	2024-03-06	J.P. Morgan Securities LLC
2024-02-06	Jacob Chacko	Director	40,000	$480,000	2024-02-06	J.P. Morgan Securities LLC
2023-07-05	Jacob Chacko	Director	20,000	$160,000	2023-07-05	J.P. Morgan Securities LLC
2023-06-26	Jacob Chacko	Affiliate	20,000	$160,561	2023-06-26	J.P. Morgan Securities LLC

Showing 1–16 of 16 filings

Key facts CIK 1796280 CUSIP 68622P109 13F (30d) 176 filings 175 filers Visit website Investor relations